首页> 外文期刊>Arthroscopy: the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association >Long-term degradation of poly-lactic co-glycolide/β-tricalcium phosphate biocomposite anchors in arthroscopic bankart repair: A prospective study
【24h】

Long-term degradation of poly-lactic co-glycolide/β-tricalcium phosphate biocomposite anchors in arthroscopic bankart repair: A prospective study

机译:关节镜下堤修复中聚乳酸共乙交酯/β-磷酸三钙生物复合材料锚的长期降解:一项前瞻性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To evaluate, using magnetic resonance (MR), the biological efficacy of anchors made of 30% β-tricalcium phosphate and 70% poly-lactic co-glycolide (PLGA) used for the repair of Bankart lesions after shoulder instability. Methods: Twenty consecutive patients who were candidates for surgical treatment for unidirectional, post-traumatic shoulder instability were treated arthroscopically with anchors made of 70% PLGA plus 30% β-tricalcium phosphate preloaded with OrthoCord suture (DePuy Mitek, Raynham, MA). Fifteen of them were evaluated by MR at least 16 months after the intervention. A second evaluation was performed at least 12 months after the first evaluation in the patients in whom implanted anchors were still visible at the first evaluation (n = 5) with a low-intensity signal in all sequences. Two radiologists, with different amounts of experience (15 and 3 years), separately evaluated the MR patterns of the trabecular glenoid bone, the walls of the bone tunnel, and the signal from the anchors. The following parameters were considered in the MR evaluation: integrity of the tunnel edge (grade 0 to 2), intensity of the signal from the anchor site (grade 1 to 3), and presence of cystic lesions. The normal signal from the glenoid trabecular bone has been used as the reference parameter. The anchors were considered independent variables, and thus each one was analyzed individually, even in the same patient. At the final clinical follow-up, a Rowe questionnaire was filled out for each patient. Results: Overall, 44 anchors were evaluated (33 anchors at the first follow-up and 11 anchors at the second follow-up). The mean follow-up period was 28.6 months. With the exception of 2 patients (10%), none of the patients had any episodes of dislocation, having satisfactory postoperative results. No cystic lesions were detected by MR imaging. The interobserver concordance between the 2 radiologists calculated with the Cohen κ was substantial (κ = 0.780 and κ = 0.791 for integrity of tunnel edge and for intensity of signal from anchor site, respectively). Both the integrity of the tunnel border and the intensity of the signal at the site of the anchors that had been implanted more than 24 months before the evaluation were significantly different from those of anchors implanted less than 24 months before the evaluation (tunnel border grade of 0 in 41%, 1 in 50%, and 2 in 9% v 0 in 4.5%, 1 in 50%, and 2 in 45.5% [P =.003]; anchor signal grade of 1 in 41%, 2 in 45.5%, and 3 in 13.5% v 1 in 13.5%, 2 in 41%, and 3 in 45.5% [P =.03]). Analysis of the linear contrasts (analysis of variance) showed a linear increase in the mean values for time to increased tunnel border grade (grade 0, 22 ± 4 months; grade 1, 27 ± 8 months; and grade 2, 29 ± 5 months [P =.02]) and grade of intensity of the signal in the anchor site (grade 1, 24 ± 6 months; grade 2, 26 ± 7 months; and grade 3, 29 ± 7 months [P =.05]). Conclusions: Anchors made of 30% β-tricalcium phosphate and 70% PLGA showed excellent biological efficacy, without causing significant cystic lesions, producing gradual changes in the MR signal that seems to become equivalent to that of the glenoid trabecular bone at a mean of 29 months after implantation. Level of Evidence: Level IV, therapeutic case series.
机译:目的:利用磁共振(MR)评估由30%β-磷酸三钙和70%聚乳酸共乙交酯(PLGA)制成的锚钉在肩部不稳后修复Bankart病变中的生物学功效。方法:连续20例因外伤后单向性肩关节不稳而需要手术治疗的患者接受关节镜检查,用70%PLGA加30%预先装有OrthoCord缝线的De-Putricalcium制成的锚钉(DePuy Mitek,Raynham,MA)。干预后至少16个月,对其中15例进行了MR评估。在第一次评估后至少12个月,对所有顺序均低强度信号的首次评估(n = 5)仍可见植入锚的患者进行了第二次评估。两位具有不同经验(15年和3年)的放射科医生分别评估了小梁盂盂骨的MR模式,骨隧道的壁以及锚钉发出的信号。在MR评估中考虑了以下参数:隧道边缘的完整性(0至2级),来自锚固位点的信号强度(1至3级)和囊性病变的存在。来自盂小梁骨的正常信号已用作参考参数。锚被认为是独立变量,因此即使在同一位患者中,也要分别分析每个锚。在最后的临床随访中,为每位患者填写了Rowe调查表。结果:总体上,评估了44个锚(第一次随访中33个锚,第二次随访中11个锚)。平均随访时间为28.6个月。除2例患者(10%)外,所有患者均无脱位发作,术后效果令人满意。 MR成像未检测到囊性病变。用Cohenκ计算得出的两位放射线医师之间的观察者一致性很高(分别为隧道边缘的完整性和锚点信号强度的κ= 0.780和κ= 0.791)。在评估前24个月以上植入的锚的隧道边界的完整性和信号强度与评估前24个月以内植入的锚的隧道边界的完整性(隧道边界等级为0 in 41%,1 in 50%和2 in 9%v 0 in 4.5%,1 in 50%和2 in 45.5%[P = .003];锚定信号等级为1 in 41%,2 in 45.5 %和13.5%中的3相对于13.5%中的1、41%中的2和45.5%中的3 [P = .03])。线性对比分析(方差分析)显示,增加隧道边界坡度(0级,22±4个月; 1级,27±8个月; 2级,29±5个月)所需时间的平均值呈线性增加[P = .02])和锚点的信号强度等级(1、24±6个月; 2、26±7个月; 3、29±7个月[P = .05]) 。结论:由30%的β-磷酸三钙和70%的PLGA制成的锚固剂具有出色的生物学功效,而不会引起明显的囊性病变,其MR信号逐渐改变,似乎与盂小梁骨的平均等效,为29植入后的几个月。证据级别:IV级,治疗病例系列。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号